Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Want to save for a house quickly? Explore various ways to accumulate savings faster and achieve your homeownership goals.
18,849 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
A surge of voter anger over AI policy is triggering resignations and election setbacks for lawmakers, widening the ga...
CT3 pivots to a dedicated Storage Contracts model to scale its decentralized storage network. The move promises faste...
A unique tax window opens after the last paycheck and before first RMDs, offering a potential 12% rate for early reti...
October brings more than a monthly paycheck notice. This article explores three critical updates the SSA should share...
When a CEO sells stock, investors listen. This article breaks down what the Electronic Arts CEO's roughly $1 million ...
If you’re wondering whether you should uber stock before the upcoming investor update, you’re not alone. This guide b...
PulteGroup accelerates its shift toward build-to-order homes to support margins as the 2026 housing market stays vola...
Crypto hedge funds started 2026 with losses as volatility rose, prompting a shift to market-neutral and relative-valu...
A $20 million unrestricted gift to Santa Barbara City College from Mackenzie Scott is under investigation after the b...
Bill Gates manages a massive charitable portfolio with a striking concentration: about 30% of its value sits in a sin...
As AI and data demand surge, investors eye NuScale Power and the small modular reactor trend. Can nuscale power next ...